"Mesothelioma is a hideous disease that is inevitably fatal." Lord Philiip's opening words in Sienkiewicz v Grief (UK) Ltd remain sadly true, yet there is some cause for cautious optimism that new drugs are capable of significantly extending life expectancy while maintaining a high quality of life.
In the latest episode of the Kings Chambers Debrief Podcast, Nigel Poole QC, Michael Rawlinson QC and Jeremy Roussak discuss the various mechanisms by which defendants (and their insurers) can be induced and, if necessary, forced to fund treatment for mesothelioma.
The podcast is available here and can be streamed on iTunes and Spotify.
For more information regarding our podcast series or to request a copy of the factsheet for Episode 7 "Mesothelioma and Immunotherapy" please contact us via podcast@kingschambers.com
Have We Got Planning News for You Season 4 Episode 6 : with Jennie Daly, Group Operations…
© Copyright 2021 Kings Chambers. All rights reserved.
Please click here to view our current guidelines
We have placed cookies on your device to help make this website better. You can view our cookie policy here. Continue using site